Immutep (IMMP) Gains from Investment Securities (2016 - 2024)
Immutep (IMMP) posted Gains from Investment Securities of $82587.0 for Q2 2024, down 11.13% on a QoQ basis from $92934.2 in Q2 2023, and down 11.13% year-over-year from $92934.2 in Q3 2023.
Immutep (IMMP) Gains from Investment Securities (2016 - 2024) Analysis & Trends
Immutep's Gains from Investment Securities history runs 5 years deep, the most recent figure standing at $82587.0 for Q2 2024.
- Quarterly Gains from Investment Securities fell 11.13% year-over-year to $82587.0 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was $1.6 million (up 6.31% YoY) and the FY2024 annual result came in at $82587.0, down 11.13% from the prior year.
- Gains from Investment Securities was $82587.0 for Q2 2024 at Immutep, down from $92934.2 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $751378.1 in Q2 2020 and bottomed at $82587.0 in Q2 2024.
- A 3-year average of $308966.4 and a median of $92934.2 in 2023 frame the typical range for Gains from Investment Securities.
- Annual changes were most pronounced in 2020 — Gains from Investment Securities advanced 7.6% — and 2024, when it declined 11.13%.
- Immutep's Gains from Investment Securities stood at $751378.1 in 2020, then plunged by 87.63% to $92934.2 in 2023, then declined by 11.13% to $82587.0 in 2024.
- Business Quant data shows IMMP's Gains from Investment Securities at $82587.0 in Q2 2024, $92934.2 in Q2 2023, and $751378.1 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.27 Bn | 467.47 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.18 Bn | 114.93 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.32 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Immutep | 573.16 Mn | 573.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 82,586.97 |
| Jun 30, 2024 | 82,586.97 |
| Jun 30, 2023 | 92,934.18 |
| Jun 30, 2023 | 92,934.18 |
| Jun 30, 2020 | 751,378.14 |
| Jun 30, 2020 | 751,378.14 |
| Jun 30, 2019 | 698,283.30 |
| Jun 30, 2019 | 698,283.30 |
| Jun 30, 2016 | -13,808.77 |
| Jun 30, 2016 | -13,808.77 |